Wednesday, 27 February 2019

Global Auto-injectors Market is expected to peak demand with Featuring Expert Panel to 2024

ResearchMoz presents professional and in-depth study of "Auto-injectors Market, Global Forecast by Application (Anaphylaxis, Multiple Sclerosis, etc.), Product Types, Usability, Distribution Channels, Regions & Companies".

Global auto-injectors market is expected to be more than USD 5 Billion by 2024. According to Renub Research analysis auto-injectors market will grow at double digit CAGR from 2018-2024 due to auto-injectors self-administration features which ultimately reduces the patients drug delivery cost.

Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1886750

Increasing prevalence of anaphylaxis, new formulations and new drug delivery systems, rising self-medication practices, government reimbursements and growing demand for targeted drug delivery systems for treatments of chronic diseases are some other driving forces for this market. However, regulatory hurdles for approval of new devices and Mylan’s EpiPen prices in United States are some of the key challenges for the auto-injectors market. From November 2004 to May 2016, EpiPen price has grown close to 500 percent in United States.

Auto-injector is a healthcare device used for fixed doses for the particular drug. It has two types of design prefilled and fillable. Auto-injectors design support user-friendly and are intended for self-administration by untrained people, by patients. In context of auto-injectors usability, it is available in re-usable and disposable form.

Renub Research report titled “Auto-injectors Market Global Forecast by Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types (Prefilled, Fillable),  Usability (Reusable, Disposable), Distribution Channels (Online Pharmacies, Retail Pharmacies, Others) Regions (North America, Europe, Asia Pacific, Middle East & Africa), Companies (Antares Pharma, Mylan N.V, Amgen Inc, Novartis AG, Bayer AG)” studies the global auto-injectors market and provides an all-encompassing analysis of the key growth drivers and challenges, market trends, key players and their projections for the future.

By Application - Market Segmentation

Global auto-injectors market has been segmented by application such as Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others. Anaphylaxis is the leading application in global auto-injectors market. Multiple Sclerosis and Rheumatoid Arthritis are other two popular applications in this market place.

By Product Design Types - Market Segmentation

Global auto-injectors market has been studied by auto-injectors design types. Prefilled and Fillable is covered to define the global market by design types. According to our analysis, we found that Prefilled control majority share in this market place.

By Product Usability - Market Segmentation

This report has also been studied by product usability such as Reusable and Disposable. Disposable auto-injectors are driving this market place.

By Distribution Channels - Market Segmentation

In the global auto-injectors market place, online pharmacy channel is showing good growth for selling the auto-injectors across the globe. The other channel studied in the report is Retail pharmacy.

By Region - Market Segmentation

Auto-injectors market by region has been segmented into North America, Europe, Asia Pacific, Middle East & Africa. North America is a leading market place due to increasing prevalence of anaphylaxis, favorable reimbursement policies and increase in healthcare expenditure.

Client can purchase this report in sections through Purchase by Chapter Tab given above

All companies in this report has been covered with the following view points

    Company Overview
    Company Initiatives
    Financial Insight

Key Players

Some of the key players in the global auto-injectors market include Antares Pharma, Mylan N.V, Amgen Inc, Novartis AG, Bayer AG.

The report has been analyzed from 8 major viewpoints

    Applications
    Design Types
    Usability Types
    Distribution Channels
    Regions
    Companies
    Growth drivers
    Challenges

Segmentation based on Applications

    Anaphylaxis
    Multiple Sclerosis
    Rheumatoid Arthritis
    Others

Segmentation based on Design Types

    Prefilled
    Fillable

Segmentation based on Usability

    Reusable
    Disposable

Segmentation based on Distribution Channels

    Online Pharmacies
    Retail Pharmacies
    Others

Segmentation based on World Regions

    North America
    Europe
    Asia Pacific
    Middle East & Africa

Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1886750

Company Details

    Antares Pharma
    Mylan N.V
    Amgen Inc
    Novartis AG
    Bayer AG.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/

No comments:

Post a Comment